inositol phosphorylceramide synthase inhibitors

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinositol phosphorylceramide synthase inhibitors
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInositol phosphorylceramide synthase inhibitors
TargetsInositol phosphorylceramide synthase
Therapy Area/IndicationsMeningitis, Cryptococcal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmplyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmplyx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMeningitis, Cryptococcal

Other Information

ATC CodeN/A
Related LinksN/A